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ABSTRACT 
Norovirus infections have been described as self-limiting diseases of short duration. An 
investigation of a norovirus outbreak in a university hospital provided evidence for severe 
clinical features in patients with several underlying diseases. Clinical outcomes of norovirus 
infection were defined. Risk-factor analysis targeting underlying diseases and medication was 
performed using multivariate analyses. In five outbreak wards, 84 patients and 60 nurses 
were infected (an overall attack rate of 32% in patients, and 76% in nurses). The causative 
agent was the new variant Grimsby virus. Severe clinical features, including acute renal 
failure, arrhythmia and signs of acute graft organ rejection in renal transplant patients, were 
observed in seven (8.3%) patients. In multivariate analyses, cardiovascular disease (OR 17.1, 
95% CI 2.17–403) and renal transplant (OR 13.0, 95% CI 1.63–281) were risk-factors for a 
potassium decrease of >20%. Age >65 years (OR 11.6, 95% CI 1.89–224) was a risk-factor 
for diarrhoea lasting >2 days. Immunosuppression (OR 5.7, 95% CI 1.78–20.1) was a risk-
factor for a creatinine increase of >10%. Norovirus infections in patients with underlying 
conditions such as cardiovascular disease, renal transplant and immunosuppressive therapy 
may lead to severe consequences typified by decreased potassium levels, increased levels of 
C-reactive protein and creatine phosphokinase. In the elderly, norovirus infection may lead to 
an increased duration of diarrhoea. Therefore patients at risk should be hospitalised early and 
monitored frequently. Strict preventional measures should be implemented as early as 
possible to minimise the risk of nosocomial outbreaks. 
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INTRODUCTION 
Norovirus (former Norwalk-like virus) infection, well-known as 'winter vomiting disease', has 
been described as a short self-limiting disease characterised by sudden onset of nausea, 
vomiting and diarrhoea. In adult volunteer studies and investigations of previously healthy 
individuals [1–6], clinical symptoms such as abdominal pain, nausea, vomiting, headache and 
chills have been reported. In many outbreak investigations, the mild self-limiting character of 
the illness associated with norovirus infection has been emphasised. 
In 2002, unusually high numbers of norovirus infections were reported in Germany [7] and 
elsewhere [8,9]. Compared with 2001, the incidence of norovirus infection in Germany 
increased five-fold from 11 cases/100 000 population to 57 cases/100 000 population. The 
peak incidence was attributed to outbreaks occurring during the winter (weeks 41–53). During 
this period, outbreaks affected wards at a university hospital in northern Germany. The first 
outbreak occurred in a closed psychiatric ward in November, but the epidemic subsequently 
reached four other sections of the hospital, with particularly severe problems in the 
departments of cardiology and nephrology. This report describes the impact of norovirus 
infection in these settings, which was much greater than was anticipated on the basis of 
information published previously. 
MATERIALS AND METHODS 
Case definition 
Between 1 November 2002 and 31 January 2003, all patients and staff members from one of 
the five studied outbreak wards who were affected with a sudden onset of diarrhoea (three or 
more episodes of loose stools in a 24-h period and/or vomiting [10]), were included as cases. 
Cases were considered to be norovirus-positive if samples from at least two patients from the 
same ward were positive by norovirus-specific RT-PCR tests. As all the included patients and 
staff members came from five wards, they were regarded as epidemiologically linked to each 
other within each ward. Patients admitted with clinical signs were regarded as index cases, 
and patients admitted 48 h before developing clinical signs were regarded as nosocomial 
cases. 
Data collection 
Data were collected prospectively during the outbreaks. The attack rate of the patients or staff 
members of each ward was calculated by dividing the number of cases in each group by the 
total number of patients or staff members potentially at risk. The population at risk was 
defined as all individuals working in or admitted to the ward in the period from the onset of 
clinical symptoms of the first patient until 2 days after the last patient became symptom-free. 
For the calculation of nosocomial incidence, index cases (patients) were ignored. 
Staff members were interviewed and patient charts were reviewed to assess patient history 
(underlying disease) and clinical signs such as diarrhoea and vomiting. Data were also 
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collected concerning potassium, creatinine and C-reactive protein (CRP) levels, radiological 
examinations (abdominal X-rays), histology (renal biopsy), other invasive procedures, 
therapeutic measures taken (rehydration therapy, immunosuppressive therapy, use of 
metoclopramide and loperamide) and indicators of complications (haemodialysis, death, renal 
biopsy). For one patient, clinical data were not available. 
Risk-factor analysis 
The following potential risk-factors were analysed: age >65 years; gender; underlying disease 
(cardiovascular disorders, pulmonary disorders, gastroenterological disorders, autoimmune 
disease, malignancy, trauma, psychiatric disorder, renal disorder, renal transplant, 
haemodialysis); immunosuppression (steroids, methotrexate, cyclosporine A, tacrolimus, 
etc.); and symptomatic treatment (metoclopramide and loperamide). Nosocomial acquisition 
of the infection was also included in the analysis. Relapses were defined as a new period of 
either diarrhoea or vomiting after a symptom-free interval of 48 h. Three norovirus-positive 
patients were excluded from risk-factor analyses because they were also positive for other 
gastroenteric pathogens (two were positive for Clostridium difficile toxin; one was positive for 
adenovirus). Only those patients with complete data for tested outcomes were included in the 
analysis. Patients who were norovirus-negative were also included because norovirus was 
the most likely pathogen according to their epidemiological setting (in place and time) and 
because no other pathogens were detected despite careful diagnostic procedures. 
Furthermore, as most of the 'negative' stool specimens were sent to the laboratory when 
symptoms had already resolved, it was concluded that these patients were probably no longer 
shedding norovirus. 
Laboratory diagnostics 
Stool specimens were assayed for the presence of noroviruses by nested RT-PCR as 
described previously [11]. For confirmation and strain characterisation, samples were sent to 
the National Institute of Public Health and the Environment (RIVM), Bilthoven, The 
Netherlands. Samples were assayed for virus RNA, and PCR products were sequenced as 
described previously [12]. Sequences were aligned using the database of the Foodborne 
Viruses in Europe project [13]. In addition, all stool specimens were cultured for 
enteropathogenic bacteria, assayed for C. difficile toxin, and investigated for viral pathogens 
by electron-microscopy. 
Statistical analysis 
Categorical variables were compared using chi-square or Fisher's exact test; ORs and 
95% CIs were calculated using Epi Info v.6.04c (CDC, Atlanta, GA, USA). All variables were 
evaluated by multiple logistic regression analysis with stepwise variable selection for inclusion 
in the final logistic regression model. SAS software was used for all multivariate analyses 
(SAS Institute, Inc., Cary, NC, USA). 
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RESULTS 
Epidemiology 
The five wards involved in the outbreak belonged to the psychiatry, nephrology, 
gastroenterology, cardiology and trauma departments. In total, 84 patients met the clinical 
and epidemiological case definition of norovirus infection, and 72 patients acquired their 
infection nosocomially. Analysis of the outbreaks in each ward showed patterns characteristic 
of person-to-person transmission, except for the trauma ward, in which there were many 
cases apparent on the first day, followed by a pattern characteristic of person-to-person 
transmission on subsequent days. Food- or water-borne transmission were ruled out because 
all other unaffected wards of the hospital received food and water from the same sources. 
Thirteen patients were admitted with the disease from the community. 
Stool specimens from 41 patients were assayed by norovirus RT-PCR. Most (n = 27; 66%) 
were positive, but 14 (34%) were negative. Each case patient from whom no stool specimen 
was available, or who had a negative norovirus PCR, was linked epidemiologically to 
confirmed cases. Four samples were referred to RIVM for confirmatory testing and 
sequencing. All sequences were identical, and clustered with the new variant Grimsby virus 
[14]. Bacterial cultures of all stool specimens failed to yield enteropathogenic bacteria. Apart 
from three patients who were excluded from risk-factor analysis, all other stool specimens 
tested were negative for C. difficile toxin and other viruses. 
In total, 79 staff members were involved (60 nurses, 19 other staff members). The attack rate 
in nurses was twice as high as the attack rate in the patient group (Table 1) (p < 0.001). 
Because this was unusual, staff were interviewed to assess possible common sources of 
exposure. There were no meetings in or outside the clinic with the potential for common food 
consumption. Attack rates in other staff members could not be determined because they were 
responsible for several wards and therefore the denominator population was variable. 
Clinical symptoms and complications 
Staff members had self-limiting vomiting or diarrhoea, or both, for episodes lasting <48 h. 
Only one nurse required admittance to the hospital for symptomatic treatment with 
intravenous saline. 
The main clinical feature with patients was diarrhoea, which affected 94% of patients. Only 
68% of the patients developed vomiting (Table 2). The median duration of clinical symptoms 
was 1 day (range 1–7 days). In total, 38 (45%) patients were treated with intravenous saline 
infusions. The severity of dehydration in two patients led to somnolence; they had been 
drowsy, but were arousable to normal level at admission. Of 22 patients with increased serum 
creatinine levels, three required haemodialysis. Creatinine levels in the outbreak population 
increased by a mean of 35% (SD ± 25.7%). The median increase in serum creatine was 
23 µmol/L during the infection episode. Diarrhoea and vomiting also led to potassium loss, 
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with potassium decreases of >10% in 18 patients, and >20% in seven patients. CRP levels 
were available for 57 patients (mean CRP level of 68.5 mg/L; SD ± 55 mg/L; median 58 mg/L; 
normal <5 mg/L). 
One patient, suffering from ventricular tachycardias, developed three episodes of ventricular 
tachycardias and needed a cardioversion. Another patient could not reach the bathroom in 
time, slipped while vomiting and fell, suffering bruises. In two renal transplant patients, 
immunosuppressive therapy with sirolimus and mycophenolate mofetil hydrochloride had to 
be stopped because diarrhoea led to fever and severe dehydration, with instability of the 
cardiovascular system. No patient died while clinical signs of norovirus infection were 
apparent, but three patients died during the following 2 weeks. The underlying diseases of 
these patients were Klatskin-cancer (renal failure developed in this patient), active lupus 
erythaematodes with ulcerations of both legs (renal failure developed while norovirus 
symptoms were present), and heart failure in an elderly patient who died with severe 
nosocomial pneumonia; the prognosis had been poor for all three cases before norovirus 
infection. In total, 14 patients relapsed after being symptom-free for 48 h (range 3–9 days; 
mean 4.3 days, SD ± 2.5 days). 
Table 3 summarises the univariate and multivariate risk-factor analyses. Relapses or 
medication with metoclopramide or loperamide were not significant risk-factors for any 
defined outcomes (data not shown). 
DISCUSSION 
Lopman et al.[15] questioned the assumption that norovirus gastroenteritis is a trivial disease 
after analysing data from norovirus outbreaks in England and Wales during 1992–2000. It has 
been suggested that norovirus infection could become an important factor contributing to the 
poor outcome of patients already weakened by other conditions [16]. Moreover, Lopman 
et al.[17] suggested that 'sick patients get sicker', referring to the length of diarrhoeal 
episodes for hospitalised patients compared with those in nursing homes. However, no details 
of the burden of disease in at-risk populations have been published previously. 
The starting point for the present investigation was the observation of severe complications of 
norovirus infection in a few patients during a large hospital outbreak. It was noted that more 
patients developed diarrhoea rather than vomiting, which is in contrast to published findings 
[4]. However, norovirus includes a diverse group of viruses that segregate into lineages 
termed genogroups (GG) and genotypes. Most outbreak strains in closed settings (hospitals, 
nursing homes) have been characterised as GG II, with genotype II/4 (Grimsby) 
predominating [18]. In 2002, a new variant Grimsby virus emerged across Europe and the 
USA. In Europe, the emergence was associated with a steep increase in the total number of 
outbreaks reported in almost all countries involved in the Foodborne Virus in Europe network 
[13,14]. The outbreak in the present study was also caused by this new variant GGII/4 
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(unpublished data). Therefore, the pattern of illness that was observed may not be typical of 
other noroviruses. 
In the present study, symptomatic norovirus infection lasted longer than expected (1–7 days) 
and relapses occurred. Protective factors against a longer duration were underlying diseases 
with a low degree of immunosuppression, such as trauma, gastrointestinal disorders and 
malignancies. Prolonged shedding over a period of 120 days has been described previously 
[19] in an intestinal transplant recipient; it was shown that a chronic norovirus infection (GG II, 
genotype Miami Beach) was the cause, and only a reduction in immunosuppressive therapy 
ended the episodes of diarrhoea and enteritis. Unfortunately, follow-up stool samples could 
not be obtained in the present study. Therefore, it is unknown whether any of the 
immunocompromised patients developed a chronic infection. 
An intriguing novel feature was the occurrence of relapses of norovirus infections in 14 
patients. It is not clear whether these cases represented true relapses, or a rebound of 
symptoms following rehydration. However, the interval between relapses ranged from 3 to 
9 days. In one patient, a follow-up sample was positive by RT-PCR, but most patients were 
not sampled later in the course of the disease. There was no significant risk-factor associated 
with relapses, so this effect may be attributed to the new variant virus. 
The need for haemodialysis and cardioversion in three patients focused attention on serum 
creatinine and potassium levels [20]. Surprisingly, the effect of illness on potassium levels, 
serum creatinine levels and CRP levels appeared high for a 'trivial' viral infection, so these 
parameters were included as outcome measures. Gendrel et al.[21] found elevated CRP 
levels (>20 mg/L) in 61 (26%) of 236 children suffering from viral gastroenteritis, whereas in 
the present study, 42 (73%) of 57 patients had elevated CRP levels. 
Recently published data [15] suggest that complications of norovirus infection arise 
predominantly in the elderly. In the present study, individuals aged >65 years were associated 
significantly with longer diarrhoeal episodes. Cardiovascular disease and renal transplant 
were risk-factors for potassium loss; immunosuppressive therapy was a risk-factor for raised 
creatinine; and immunosuppressive therapy was a risk-factor for high CRP levels. Trauma 
was protective for longer diarrhoeal episodes, reflecting the fact that these patients belonged 
to the healthy population. Thus, this population may be considered as a small internal control 
group; indeed, OR were <1 for all outcomes except 'vomiting for >1 day', thereby providing 
evidence that healthy individuals develop predominantly mild symptoms. 
In the present study, only 27 of 84 patients tested positive for norovirus. During an ongoing 
outbreak, it is not possible to obtain stool specimens from all patients involved; patients caring 
for themselves often forget to obtain specimens, and the wards involved were advised to 
discharge patients as early as possible. Hence, patients with a short course of infection might 
not have had the opportunity to provide specimens. Furthermore, norovirus-negative patients 
often submitted specimens after the symptoms had resolved, indicating that norovirus did not 
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persist for long periods in these patients. Nevertheless, the possibility cannot be discounted 
that either a small group of norovirus-negative patients might have been included in the study, 
or that norovirus-positive patients without symptoms were missed. 
Another limitation concerns the patient groups investigated. The outbreak was confined to 
only five wards from five different departments. Consequently, only patients from these 
departments were investigated. Thus, data are lacking for other patient groups, particularly 
haematological, pneumological, surgical and paediatric patients. 
There were marked differences in attack rate, perhaps depending on factors associated with 
the ward and staff group. For example, dementia patients, for whom isolation procedures are 
difficult to establish, were treated on the psychiatric ward. In contrast to attack rates reported 
by the CDC [9], nursing staff were at higher risk of infection compared with patients, perhaps 
because the present study only included staff members who had been working on the ward 
during the outbreak period in the denominator population. In cardiology, educational 
interventions concerning the prevention of transmission of noroviruses were started at an 
early stage, which may have resulted in the lowest attack rate. 
The outbreak investigation demonstrated that 'sick patients got sicker' when acquiring a 
norovirus infection. Furthermore, at-risk populations were identified for several clinical 
outcomes. Patients with cardiovascular disease, those receiving immunosuppressive therapy, 
the elderly and organ transplant recipients were at higher risk of a severe clinical outcome. 
These patients should be monitored frequently when suffering from norovirus infection. 
Although many recommendations exist for preventing transmission of noroviruses [22], the 
potentially severe impact of norovirus outbreaks in frail hospital populations has been 
underestimated. An important recommendation should focus on prevention of such outbreaks 
in hospitals, especially when immunocompromised patients are treated. Immunocompromised 
patients should be educated about possible severe courses of 'trivial' gastrointestinal 
infections, and should be instructed to consult a physician as early as possible to allow 
monitoring for possible complications. The present findings underline the importance of 
applying stringent infection control measures when dealing with norovirus infections. 
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